-
November 22: The Week in Cancer News
Pancreatic cancer surge in younger people has not led to a rise in deaths, and researchers will study long-term survivors to better understand cancer responses.
by Eric Fitzsimmons
-
November 15: The Week in Cancer News
Complications can affect men years after prostate cancer treatment, and many people eligible for lung cancer screening do not get it.
by Kevin McLaughlin
-
November 8: The Week in Cancer News
Early initiation of palliative care leads to fewer hospital admissions, and surgery that removes fewer lymph nodes is effective for localized muscle-invasive bladder cancer.
by Marci A. Landsmann
-
November 1: The Week in Cancer News
Long-term monitoring can catch side effects in childhood cancer survivors, and breast cancer screening rates remain low among transgender people.
by Thomas Celona
-
October 25: The Week in Cancer News
Asian American and Pacific Islander women face rising rates of early-onset breast cancer, and the risk for dying of COVID-19 is twice as high in people living with cancer.
by Eric Fitzsimmons
-
October 18: The Week in Cancer News
Immunotherapy lowers risk of side effects in advanced lymphoma, and an extra course of chemotherapy improves survival in cervical cancer.
by Marci A. Landsmann
-
October 11: The Week in Cancer News
Expanded dependent coverage improves cancer outcomes in young adults, and breast cancer treatment can lead to faster cell aging.
by Kevin McLaughlin
-
October 4: The Week in Cancer News
Study finds people who receive brain radiation often recover cognitive abilities over time, and report details breast cancer trends.
by Thomas Celona
-
September 27: The Week in Cancer News
Adding MRI to prostate screening can help limit overdiagnosis, and breast cancer patients who smoke have a higher risk of radiotherapy-related lung cancer.
by Eric Fitzsimmons
-
September 20: The Week in Cancer News
The AACR spotlights cancer advances and challenges in new report, and the FDA approves second CDK 4/6 inhibitor to reduce risk of recurrence in early-stage breast cancer.
by Marci A. Landsmann
Cancer Talk
Researchers Tackle Immune-related Adverse Effects
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin